Search Results - "Karlas, T"

Refine Results
  1. 1

    Editorial: the impact of steatosis on liver stiffness quantification is minimal—Authors’ reply by Karlas, T., Petroff, D., Wiegand, J.

    Published in Alimentary pharmacology & therapeutics (01-05-2018)
    “…Linked Content This article is linked to Karlas et al and Hassan and Tapper papers. To view these articles visit https://doi.org/10.1111/apt.14529 and…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Assessment of spleen stiffness using acoustic radiation force impulse imaging (ARFI): definition of examination standards and impact of breathing maneuvers by Karlas, T, Lindner, F, Tröltzsch, M, Keim, V

    Published in Ultraschall in der Medizin (01-02-2014)
    “…Spleen elastography is a promising method for the characterization of portal hypertension in cirrhotic individuals. However, standardized examination…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Acoustic radiation force impulse (ARFI) elastography in acute liver failure: necrosis mimics cirrhosis by Karlas, T F, Pfrepper, C, Rosendahl, J, Benckert, C, Wittekind, C, Jonas, S, Moessner, J, Tröltzsch, M, Tillmann, H L, Berg, T, Keim, V, Wiegand, J

    Published in Zeitschrift fur Gastroenterologie (01-04-2011)
    “…Acoustic radiation force Impulse (ARFI) technology correlates shear-wave velocity with fibrosis. It can differentiate between advanced fibrosis and normal…”
    Get more information
    Journal Article
  7. 7

    Value of liver elastography and abdominal ultrasound for detection of complications of allogeneic hemopoietic SCT by Karlas, T, Weber, J, Nehring, C, Kronenberger, R, Tenckhoff, H, Mössner, J, Niederwieser, D, Tröltzsch, M, Lange, T, Keim, V

    Published in Bone marrow transplantation (Basingstoke) (01-06-2014)
    “…Hepatic complications contribute to morbidity and mortality after allogeneic hemopoietic SCT. Liver Doppler ultrasound and elastography represent promising…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Prevention of lamivudine‐resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only by Karlas, T., Hartmann, J., Weimann, A., Maier , M., Bartels, M., Jonas, S., Mössner, J., Berg, T., Tillmann, H.L., Wiegand, J.

    Published in Transplant infectious disease (01-06-2011)
    “…T. Karlas, J. Hartmann, A. Weimann, M. Maier, M. Bartels, S. Jonas, J. Mössner, T. Berg, H.L. Tillmann, J. Wiegand. Prevention of lamivudine‐resistant…”
    Get full text
    Journal Article
  16. 16

    Resistance management in chronic hepatitis B complicated by renal failure by Wiegand, J, Karlas, T, Schiefke, I, Krasselt, U, Bock, T, Mössner, J, Tillmann, H L

    Published in Clinical nephrology (01-07-2010)
    “…Therapy of chronic hepatitis B has improved by the invention of the potent nucleos(t)ide analogues entecavir, telbivudine and tenofovir disoproxil. Due to…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20